2026-01-23 - Analysis Report
## DuPont de Nemours Financial Report

### Company Overview
DuPont de Nemours is a multinational company that develops and manufactures a wide range of products for various industries, including agriculture, construction, and electronics.

### Comparison of Return Rates

* Cumulative return of review stock: 25.15%
* Cumulative return of comparison stock (S&P 500, VOO): 92.53%
* Divergence (max: 16.30, min: -97.30, current: -70.80, relative divergence: 23.30%)

### Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -7.0% | 23.4% | -11.0% | 1.1 | 13.3B |
| 2017-2019  | -36.0% | 23.4% | -54.0% | 1.2 | 11.2B |
| 2018-2020  | -58.0% | 54.6% | -79.0% | 1.2 | 12.5B |
| 2019-2021  | -4.0% | 54.6% | -47.0% | 1.1 | 14.2B |
| 2020-2022  | 13.0% | 43.9% | 15.0% | 1.1 | 12.0B |
| 2021-2023  | -2.0% | 31.7% | -3.0% | 1.1 | 13.5B |
| 2022-2024  | -11.0% | 28.7% | -30.0% | 1.0 | 13.4B |
| 2023-2025  | 36.0% | 20.3% | -26.0% | 1.1 | 16.8B |

### Recent Stock Price Fluctuations

* Close: $43.79
* Last-market: {'price': 43.79, 'previousClose': 43.38, 'change': 0.95}
* 5-day SMA: $43.14
* 20-day SMA: $42.39
* 60-day SMA: $40.13

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence

* Market Risk Indicator (MRI): 0.90
* RSI: 70.42
* PPO: -0.14
* Recent (20 days) relative divergence change: -1.80 (-): worsening
* 7-day Rank change: 33 (+): rank up
* 7-day Dynamic Expected Return change: -13.50 (-): worsening
* Expected Return: -206.20%
* Expected excess return compared to S&P 500 if invested long-term: worsening

### Recent News & Significant Events

* [2026-01-22] DuPont de Nemours Inc (DD) Stock Price Up 3.46% on Jan 22 - GuruFocus (news.google.com)
* [2026-01-22] Is DuPont de Nemours (DD) Fairly Priced After 36% One Year Share Price Gain? - Yahoo Finance Singapore (news.google.com)
* [2026-01-22] 28,931 Shares in DuPont de Nemours, Inc. $DD Bought by Millington Financial Advisors LLC - MarketBeat (news.google.com)
* [2026-01-21] DuPont to detail 2025 results in Feb. 10 earnings call - Stock Titan (news.google.com)
* [2026-01-08] DuPont Slashes Dividend, And That Might Be Their Best Move For Sustainable Growth - Seeking Alpha (news.google.com)
* [2025-11-21] DuPont de Nemours Stock: Strong Cash Flow Poised for a Re-Rating? - Trefis (news.google.com)

### Analyst Opinions

Analyst Consensus:
- Key: Strong_Buy
- Mean (1=StrongBuy~5=Sell): 1.47 (~Strong Buy)
- Opinions: 16
- Target Price (avg/high/low): 49.19 / 56.00 / 44.00

### Recent Earnings Analysis

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-11-07 | 0.1 | 0.89 B$ |
| 2025-08-08 | 0.01 | 0.83 B$ |
| 2025-05-07 | 0.07 | 0.76 B$ |
| 2024-11-08 | 0.15 | 0.69 B$ |
| 2025-11-07 | 0.15 | 0.69 B$ |

### Financial Information

#### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $3.07B | 38.90% |
| 2025-06-30 | $3.26B | 37.33% |
| 2025-03-31 | $3.07B | 37.38% |
| 2024-12-31 | $3.09B | 36.38% |
| 2024-09-30 | $2.86B | 39.24% |

#### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $22.89B | -0.54% |
| 2025-06-30 | $23.06B | 0.26% |
| 2025-03-31 | $22.83B | -2.58% |
| 2024-12-31 | $23.35B | -0.51% |
| 2024-09-30 | $24.21B | 1.88% |

### Comprehensive Analysis

Based on the analysis of the provided data, DuPont de Nemours' stock price has been fluctuating, with a recent upward trend. However, the cumulative return is lower than the comparison stock (S&P 500, VOO). The Alpha, Beta analysis indicates a high Beta value, indicating high volatility. The Market Risk Indicator (MRI) indicates a high-risk investment. The RSI and PPO index indicators suggest a neutral market condition. The recent news and significant events suggest that the company is taking steps to improve its performance. The analyst opinions suggest a strong buy consensus. The recent earnings analysis indicates a stable revenue growth. Overall, the comprehensive analysis suggests that the stock is a high-risk investment with potential for long-term growth.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.